V

VistaGen Therapeutics
D

VTGN

2.00000
USD
-0.02
(-0.99%)
مغلق
حجم التداول
1,661
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
58,315,466
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
A
APVO
0.04000
(1.36%)
2.99000 USD
C
CLDX
-0.150
(-0.68%)
21.950 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
M
MNKD
-0.02500
(-0.69%)
3.59500 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
S
SUPN
-0.115
(-0.36%)
31.970 USD
T
TBPH
0.060
(0.54%)
11.110 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.